Veeva Systems Inc - Ordinary Shares - Class A

Strong Financial Performance: Veeva reported total revenue of $721 million for Q4 FY2025, exceeding guidance, and $2.75 billion for the full year, with non-GAAP operating income of $308 million in Q4 and $1.15 billion for the year. This indicates a substantial growth trajectory, reflecting a strong execution across the business.

Strategic Wins in Top 20 Pharma: The company secured a major contract with a top 20 pharmaceutical customer for its clinical platform. This aligns with a trend where large pharma seeks to consolidate their vendor base for greater strategic advantage and efficiency, though Peter Gassner emphasized that speed and alignment were key factors for this particular win.

Expansion into New Markets and AI Strategy: Veeva set a long-term revenue target of $6 billion by 2030 and announced plans for market expansion and AI product innovations. The AI offerings are being developed rapidly, with several new products in the pipeline, including bots for CRM and document classification, reflecting a positive response from early customers.